Nathalie Vanlaer, Ph.D. student at VUB Brussels presented a single-centre prospective study evaluating neurocognitive functioning in cancer survivors who were diagnosed with stage III/IV cancer of any type, and who had initiated immunotherapy at least one year prior to and who were in complete remission at the time of inclusion. A majority of the advanced cancer survivors treated with immunotherapy had objective neurocognitive impairment and a lesser proportion had subjective cognitive complaints that were correlated with psychological distress. An integrative approach, including neurocognitive functioning remediation and psychosocial support when treating cognitive complaints, seems valuable.
With the educational support of:
 |
 |
 |
 |